Skip to content

Study · Not a test of the peptide alone · 2023

5 results

Combination of metformin with liraglutide in treating HAIR-AN syndrome in children: A case report and literature review.

Li R, Li H, Yang Z, Zhang X

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences1 Sept 2023Cited by 4 (Europe PMC)

PMID38044655 (opens in a new tab)PMCIDPMC10929875 (opens in a new tab)DOI10.11817/j.issn.1672-7347.2023.230100 (opens in a new tab)PepBankPUB-38044655
Source linkPubMedAsk about this study
Jump to 5 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study5

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone5

In this study, Liraglutide was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Liraglutide.

  1. 01HumanNot a test of Liraglutide aloneCase report or seriesEfficacy outcome

    In a child with HAIR-AN syndrome, obesity was significantly improved after treatment with metformin and liraglutide together.

    In plain wordsIn one child with HAIR-AN syndrome, obesity improved after treatment with metformin and liraglutide together.

    Peptide
    Liraglutide
    Outcome
    DecreaseObesity
    Study

    n = 1

    Outcome group
    Body weight · Metabolic and weight

    Source sentences

    Summary
    Obesity, IR, hyperglycemia, menstrual disorder, and AN were significantly improved after treating with metformin and liraglutide.
    1 context sentence
    Summary · context
    A case of pediatric HAIR-AN syndrome with severe AN was admitted to the Department of Endocrinology, China-Japan Friendship Hospital.

    In this study, Liraglutide was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Liraglutide.

  2. 02HumanNot a test of Liraglutide aloneCase report or seriesEfficacy outcome

    In a child with HAIR-AN syndrome, insulin resistance was significantly improved after treatment with metformin and liraglutide together.

    In plain wordsIn one child with HAIR-AN syndrome, insulin resistance improved after treatment with metformin and liraglutide together.

    Peptide
    Liraglutide
    Outcome
    DecreaseInsulin resistance
    Study

    n = 1

    Outcome group
    Glycemic control · Metabolic and weight

    Source sentences

    Summary
    Obesity, IR, hyperglycemia, menstrual disorder, and AN were significantly improved after treating with metformin and liraglutide.
    1 context sentence
    Summary · context
    A case of pediatric HAIR-AN syndrome with severe AN was admitted to the Department of Endocrinology, China-Japan Friendship Hospital.

    In this study, Liraglutide was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Liraglutide.

  3. 03HumanNot a test of Liraglutide aloneCase report or seriesEfficacy outcome

    In a child with HAIR-AN syndrome, hyperglycemia was significantly improved after treatment with metformin and liraglutide together.

    In plain wordsIn one child with HAIR-AN syndrome, high blood sugar improved after treatment with metformin and liraglutide together.

    Peptide
    Liraglutide
    Outcome
    DecreaseHyperglycemia
    Study

    n = 1

    Outcome group
    Glycemic control · Metabolic and weight

    Source sentences

    Summary
    Obesity, IR, hyperglycemia, menstrual disorder, and AN were significantly improved after treating with metformin and liraglutide.
    1 context sentence
    Summary · context
    A case of pediatric HAIR-AN syndrome with severe AN was admitted to the Department of Endocrinology, China-Japan Friendship Hospital.

    In this study, Liraglutide was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Liraglutide.

  4. 04HumanNot a test of Liraglutide aloneCase report or seriesEfficacy outcome

    In a child with HAIR-AN syndrome, menstrual disorder was significantly improved after treatment with metformin and liraglutide together.

    In plain wordsIn one child with HAIR-AN syndrome, menstrual problems improved after treatment with metformin and liraglutide together.

    Peptide
    Liraglutide
    Outcome
    DecreaseMenstrual disorder
    Study

    n = 1

    Outcome group
    Sex hormones and fertility · Reproductive and sexual health

    Source sentences

    Summary
    Obesity, IR, hyperglycemia, menstrual disorder, and AN were significantly improved after treating with metformin and liraglutide.
    1 context sentence
    Summary · context
    A case of pediatric HAIR-AN syndrome with severe AN was admitted to the Department of Endocrinology, China-Japan Friendship Hospital.

    In this study, Liraglutide was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Liraglutide.

  5. 05HumanNot a test of Liraglutide aloneCase report or seriesEfficacy outcome

    In a child with HAIR-AN syndrome, acanthosis nigricans was significantly improved after treatment with metformin and liraglutide together.

    In plain wordsIn one child with HAIR-AN syndrome, the dark skin patches of acanthosis nigricans improved after treatment with metformin and liraglutide together.

    Peptide
    Liraglutide
    Outcome
    DecreaseAcanthosis nigricans
    Study

    n = 1

    Outcome group
    Skin and hair · Skin and wound

    Source sentences

    Summary
    Obesity, IR, hyperglycemia, menstrual disorder, and AN were significantly improved after treating with metformin and liraglutide.
    1 context sentence
    Summary · context
    A case of pediatric HAIR-AN syndrome with severe AN was admitted to the Department of Endocrinology, China-Japan Friendship Hospital.

    In this study, Liraglutide was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Liraglutide.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 11:11 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:05 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.